Skip to the page

Data / Drug companies / Calvin Scott & Co., Inc.

Calvin Scott & Co., Inc.: 34 products in the FDA NDC directory, labeler code 17224

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Calvin Scott & Co., Inc. (labeler code 17224) lists 34 products in the FDA National Drug Code Directory, covering 9 finished drugs by generic name. By type: 19 prescription drugs, 15 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on August 1, 2025.

The request: Watch Calvin Scott & Co., Inc. (FDA labeler code 17224): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
17224
Products in commercial distribution
34
Packages
111
Finished drugs by generic name
9
Prescription products
19
Over the counter products
15
Controlled substance products
Schedule III 2, Schedule IV 12
Started marketing in the last 12 months
0
Earliest marketing start
January 1, 1978
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)1955.9%
Other unapproved drugs1544.1%

Products by type

TypeProductsShare
Prescription drugs1955.9%
Over the counter drugs1544.1%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet2676.5%
Capsule617.6%
Tablet, extended release25.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
NP Thyroid17224-511TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-511TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-511TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-505TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-505TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-505TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-504TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-504TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-504TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-503TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-503TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-503TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-502TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-502TabletOther unapproved drugsAugust 1, 2025
NP Thyroid17224-502TabletOther unapproved drugsAugust 1, 2025
Phentermine Hydrochloride17224-907TabletGeneric drugs (ANDA)February 15, 2024
Phentermine Hydrochloride17224-851CapsuleGeneric drugs (ANDA)February 1, 2019
Metformin Hydrochloride Extended-Release 500mg17224-311Tablet, extended releaseGeneric drugs (ANDA)June 8, 2017
Phentermine hydrochloride17224-904TabletGeneric drugs (ANDA)January 24, 2017
Lomaira17224-840TabletGeneric drugs (ANDA)September 12, 2016
Fluoxetine17224-174CapsuleGeneric drugs (ANDA)March 16, 2015
Fluoxetine17224-171CapsuleGeneric drugs (ANDA)March 16, 2015
Phentermine Hydrochloride17224-901TabletGeneric drugs (ANDA)August 12, 2013
Phentermine17224-890CapsuleGeneric drugs (ANDA)August 15, 2012
Phentermine Hydrochloride17224-877CapsuleGeneric drugs (ANDA)August 7, 2012

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.